The present invention relates to pharmaceutical compositions based on antiinflammatory active ingredients and to the use thereof for the treatment of rheumatoid diseases. The compositions comprise lactalbumin hydrolysate or a fraction thereof. Substantially lower doses of the antiinflammatory drugs are thus possible than is conventionally necessary to achieve a particular antiinflammatory effect.
本发明涉及基于抗炎活性成分的药物组合物及其用于治疗类风湿疾病的用途。这些组合物包括乳白蛋白
水解物或其馏分。因此,抗炎药物的剂量可以大大低于达到特定抗炎效果所需的常规剂量。